文献速递静脉血栓栓塞

新型冠状病毒病-2019患者静脉血栓栓塞事件患病率的系统评价与荟萃分析

Systematic review and meta-analysis of the prevalence of venous thromboembolic events in novel coronavirus disease-2019 patients.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-12-09

该系统评价与荟萃分析纳入40项临床研究、7966例住院COVID-19患者,发现合并VTE患病率在连续患者中为13%、非ICU患者7%、ICU患者31%,ICU患者PE和DVT患病率均最高;应用VTE筛查检测可使ICU和非ICU患者的PE和DVT检出率提高三倍。

要点

  • 住院COVID-19患者VTE常见,ICU患者患病率最高(31%)。
  • ICU患者PE患病率17%、DVT患病率25%,均高于非ICU和连续患者。
  • 应用VTE筛查检测可显著提高PE和DVT检出率。

核心结论

  • VTE在住院COVID-19患者中常见,尤其在ICU患者中。
  • 针对PE和DVT的筛查检测可能较基于临床怀疑的检测显著提高ICU和非ICU COVID-19患者的检出率。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Web of Science和Embase数据库。
  • 纳入40项临床研究,共7966例住院COVID-19患者。
  • 患者分为连续组、ICU组和非ICU组,PE经CT肺动脉造影诊断,DVT经双功超声诊断。
  • 对ICU和非ICU患者中PE和DVT检测策略进行亚组分析。

主要发现

  • 合并VTE患病率:连续患者13%(95%CI 0.05-0.24;I2=97%),非ICU患者7%(95%CI 0.01-0.18;I2=93%),ICU患者31%(95%CI 0.22-0.42;I2=91%)。
  • PE患病率:ICU患者17%(95%CI 0.12-0.23),连续患者8%(95%CI 0.04-0.13),非ICU患者4%(95%CI 0.01-0.08)。
  • DVT患病率:ICU患者25%(95%CI 0.14-0.37),连续患者7%(95%CI 0.03-0.14),非ICU患者7%(95%CI 0.02-0.14)。
  • 亚组分析显示,应用VTE筛查检测时,ICU和非ICU患者的PE和DVT检出率均提高三倍。
  • 在筛查检测背景下,ICU患者PE患病率显著高于非ICU患者(37% vs 10%;P < .0001),DVT患病率也显著更高(40% vs 12%;P = .0065)。

临床怎么用

  • 对住院COVID-19患者,尤其ICU患者,应警惕VTE风险。
  • 考虑对ICU和非ICU的COVID-19患者应用PE和DVT筛查检测以提高检出率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emerging clinical evidence has shown that patients with the novel coronavirus disease-2019 (COVID-19) have complications that include venous thromboembolism (VTE), consisting of deep vein thrombosis (DVT) and pulmonary embolism (PE). The prevalence of VTE in patients hospitalized with COVID-19 is unclear. METHODS: Eligible studies on COVID-19 were collected from PubMed, Web of Science, and Embase. Patient characteristics and information were extracted for three categories of patients: consecutive, ICU, and non-ICU group. All PEs and DVTs were diagnosed by computed tomographic pulmonary arteriography and duplex ultrasound examination, respectively. A subgroup analysis of testing strategies in ICU and non-ICU patients for PE and DVT was also performed. RESULTS: Forty clinical studies involving 7966 patients hospitalized with COVID-19 were included. Pooled VTE prevalence was 13% in consecutive patients (95% confidence interval [CI], 0.05-0.24; I2 = 97%), 7% in non-ICU patients (95% CI, 0.01-0.18; I2 = 93%), and 31% in ICU patients (95% CI, 0.22-0.42; I2 = 91%). ICU patients had the highest prevalence of PE among the three groups (17% [95% CI, 0.12-0.23] vs 8% in consecutive patients [95% CI, 0.04-0.13], 4% in non-ICU patients [95% CI, 0.01-0.08]). ICU patients also had the highest DVT prevalence (25% [95% CI, 0.14-0.37] vs 7% in consecutive patients [95% CI, 0.03-0.14], and 7% in non-ICU [95% CI, 0.02-0.14]). The subgroup analysis showed a three-fold improvement in the PE and DVT detection rates in both ICU and non-ICU patients with COVID-19 when the screening test for VTE was applied. In the settings of screening tests for VTE, ICU patients have a significantly higher prevalence of PE (37% vs 10%; P < .0001) and DVT (40% vs 12%; P = .0065) compared with non-ICU patients. CONCLUSIONS: VTE is common in patients hospitalized with COVID-19, especially among ICU patients. Screening tests for PE and DVT may significantly improve detection rates in both ICU and non-ICU patients with COVID-19 than tests based on clinical suspicion.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Zhang R, Ni L, Di X, et al. Systematic review and meta-analysis of the prevalence of venous thromboembolic events in novel coronavirus disease-2019 patients. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33309903. doi:10.1016/j.jvsv.2020.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。